1. P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). (23rd June 2022) Authors: Manavalan, J. S.; Pal, I.; Pursley, A.; Ward, G.; Smyth, T.; Sims, M.; Feith, D.; Loughran, T. P.; O'Connor, O. A.; Marchi, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1293: COMBINING THE IAP ANTAGONIST, TOLINAPANT, WITH A DNA HYPOMETHYLATING AGENT ENHANCES ANTI-TUMOUR MECHANISMS IN PRECLINICAL MODELS OF T-CELL LYMPHOMA. (23rd June 2022) Authors: Sims, M.; Ward, G.; Zhang, Z.; Jueliger, S.; Davis, M.; Boxall, A.; Taylor, J.; Biondo, A.; Lyons, J.; Smyth, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S217: PRELIMINARY ANALYSIS OF THE PHASE II STUDY USING TOLINAPANT (ASTX660) MONOTHERAPY IN 98 PERIPHERAL T-CELL LYMPHOMA AND 51 CUTANEOUS T-CELL LYMPHOMA SUBJECTS WITH RELAPSED REFRACTORY DISEASE. (23rd June 2022) Authors: Michot, J.-M.; Mehta, A.; Samaniego, F.; Bachy, E.; Zinzani, P. L.; Prica, A.; Colins, G. P.; Ribrag, V; Wagner-Johnston, N.; El-Sharkawi, D.; O'Connor, O. A.; Wilcox, R.; Wang, L.; Wilson, L.; Sims, M.; Taylor, J. A.; Keer, H. N.; Foss, F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hematology journals do not sufficiently adhere to reporting guidelines: a systematic review. (27th February 2017) Authors: Wayant, C.; Smith, C.; Sims, M.; Vassar, M. Journal: Journal of thrombosis and haemostasis Issue: Volume 15:Number 4(2017) Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The non-peptidomimetic cIAP1/2 and XIAP antagonist ASTX660 promotes an anti-tumour immune response in T-cell lymphoma. (October 2020) Authors: Ferrari, N.; Ward, G.; Gewinner, C.; Jueliger, S.; Smyth, T.; Munck, J.; Davis, M.; Ferraldeschi, R.; Lyons, J.; Sims, M. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Occupational well-being and stress among early childhood professionals: the use of an innovative strategy to measure stress reactivity in the workplace. Issue 1 (1st January 2016) Authors: Nislin, M.; Sajaniemi, N.; Sims, M.; Suhonen, E.; Maldonado, E. F.; Hyttinen, S.; Hirvonen, A. Journal: Open review of educational research Issue: Volume 3:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The THESEUS space mission concept: science case, design and expected performances. Issue 1 (1st July 2018) Authors: Amati, L.; O'Brien, P.; Götz, D.; Bozzo, E.; Tenzer, C.; Frontera, F.; Ghirlanda, G.; Labanti, C.; Osborne, J.P.; Stratta, G.; Tanvir, N.; Willingale, R.; Attina, P.; Campana, R.; Castro-Tirado, A.J.; Contini, C.; Fuschino, F.; Gomboc, A.; Hudec, R.; Orleanski, P. Journal: Advances in space research Issue: Volume 62:Issue 1(2018) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗